1
/
of
1
ELK Biotechnology
SKU:ELK4310
Human NKA(Neurokinin A) ELISA Kit
Human NKA(Neurokinin A) ELISA Kit
Regular price
$458.00 USD
Regular price
Sale price
$458.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human NKA(Neurokinin A) ELISA Kit
Overview
| Product name: | Human NKA(Neurokinin A) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | NK-A; SK; Substance K; Neuropeptide K; Neurokinin K; Neuromedin L; Neuropeptide gamma |
| Assay Type: | Competitive Inhibition |
| Sensitivity: | 4.91 pg/mL |
| Standard: | 1000 pg/mL |
| Range: | 15.63-1000 pg/mL |
| Sample Type: | serum, plasma and other biological fluids |
| Assay Length: | 2h |
| Research Area: | Signal transduction;Neuro science; |
| Test principle: | This assay employs the competitive inhibition enzyme immunoassay technique. The microtiter plate provided in this kit has been pre-coated with Human NKA protein. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human NKA. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human NKA in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 1000.00 | 0.212 | — |
| 500.00 | 0.397 | — |
| 250.00 | 0.557 | — |
| 125.00 | 0.861 | — |
| 62.50 | 1.152 | — |
| 31.25 | 1.511 | — |
| 15.63 | 1.793 | — |
| 0.00 | 2.211 | — |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant NKA and the recovery rates were calculated by comparing the measured value to the expected amount of NKA in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 80-95% | 87% |
| EDTA plasma(n=5) | 82-97% | 89% |
| Heparin plasma(n=5) | 95-108% | 85% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of NKA and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 92-105% | 83-92% | 89-97% | 85-93% |
| EDTA plasma(n=5) | 86-96% | 93-104% | 89-97% | 85-94% |
| Heparin plasma(n=5) | 85-92% | 85-104% | 90-98% | 82-98% |
Share
